鶹ýɫƬ

Journal News

Breast milk from rhinos and dolphins and whales, oh my!

In study of diverse mammals, researchers find shared immunomodulatory components
Marissa Locke Rottinghaus
Aug. 29, 2023

A recent has uncovered that the components of breast milk from land and sea mammals possess immunomodulatory components that may promote healthy microbiome colonization in offspring. These findings could inform efforts to develop better formula for human and animal infants.

Bojar used mass spectrometry to identify novel milk sugars in understudied mammals, like rhinos and sheep, that have immunomodulatory properties.
The Bojar lab used mass spectrometry to identify novel milk sugars in understudied mammals, like rhinos and sheep, that have immunomodulatory properties. This is the graphical abstract for their paper titled "."

The and the recommend that mothers exclusively breastfeed their babies for the first six months of life, because it promotes infant survival and a healthy immune system. However, less than are breastfed, due to a variety of such as maternal health and lack of support and resources. Therefore, there is a need to develop formula that to promote the health of future generations.

According to , an assistant professor of chemistry and molecular biology at the University of Gothenburg in Sweden, scientists need to know more about nonhuman breast milk. Bojar oversaw the new , which was published in the journal 鶹ýɫƬ & Cellular Proteomics.

“For nearly all mammals, we have shallow or zero knowledge about what makes up their breast milk sugars,” Bojar said. “Knowledge from these species can shed light on human milk and therapeutic opportunities. Ultimately, this story is about the amazing things that nature has created and how we are just beginning to unlock their secrets. It's a tale of discovery, of nature's wonders and of the universal bond between mothers and their children.”

Bojar and colleagues examined breast milk from nine understudied mammal species: alpaca, beluga whale, black rhinoceros, bottlenose dolphin, impala, L'Hoest's monkey, pygmy hippopotamus, domestic sheep and striped dolphin. They found that the collective mammalian breast milk contained more than 100 novel milk sugars, including glucuronic acid, and these sugars were shared across species. According to Bojar, is also found in cartilage and connective tissues.

Bojar used mass spectrometry to identify novel milk sugars in understudied mammals, like rhinos and sheep, that have immunomodulatory properties.
Shared milk oligosaccharides by taxonomic order. A pie chart with the proportion of milk glycans from various mammalian orders is shown, with rare orders being grouped under “Misc.”

After identifying these new milk sugars, Bojar’s team wanted to know what purpose they serve. The team exposed macrophages, an immune cell responsible for ingesting foreign invaders, to glucuronic acid-containing milk sugars and observed how it influenced the macrophage behavior and activation. Glucuronic acid dampened macrophages’ inflammatory response to bacteria, indicating that this milk sugar could help prevent excessive immune activation, common in autoimmune diseases, and promote healthy microbiome development in infants.

“We showed that these special sugars are advisers that help the baby's immune system make better decisions,” Bojar said. “In particular, these new molecules seem to aid in the development of the infant microbiome by allowing the good kind of bacteria to colonize the infant gut.”

Bojar said his team’s future work will focus on further dissecting the novel milk sugars found in these mammals and others. He said the findings could be beneficial for creating better human formula that promotes a healthy microbiome.

“Understanding these ‘super ingredients’ can lead to exciting possibilities, such as creating better baby formula or finding new ways to strengthen our immune systems,” Bojar said. “By understanding the powerful properties of breast milk across different animals, we can potentially design better infant formulas that mimic some of these beneficial qualities. For many babies who cannot be breastfed for various reasons, this could be a game changer.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Marissa Locke Rottinghaus

Marissa Locke Rottinghaus is the Editorial Content Manager for ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.